ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018
White Matter Reference Region in PET Studies of
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 55 citations in OpenAlex.
- Cerebellar cortical amyloid deposition biasesEuropean journal of nuclear medicine and molecular imaging · 2026Article
- Regional differences inAnnals of nuclear medicine · 2026Article
- Astrocyte reactivity across the AD continuum measured by [European journal of nuclear medicine and molecular imaging · 2026Article
- White matterAlzheimer's research & therapy · 2026Article
- Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptake.The journal of prevention of Alzheimer's disease · 2026Article
- A new amyloid PET evaluation method using separated gray-matter histogram based on three-component model.Annals of nuclear medicine · 2026Article
- Quantification of [Frontiers in neuroscience · 2026Article
- Intracranial stenosis and longitudinal progression of Alzheimer's disease pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Advances in PET imaging of protein aggregates associated with neurodegenerative disease.Nature reviews. Neurology · 2025Review
- Cutoff SUVR of [Nuclear medicine and molecular imaging · 2025Article
- Motion correction of simultaneous brain PET/MR images based on tracer uptake characteristics.EJNMMI physics · 2025Article
- Daily fluid intake and brain amyloid deposition: A cohort study.Journal of Alzheimer's disease : JAD · 2025Article
- Visual and Auditory Sensory Impairments Differentially Relate with Alzheimer's Pathology.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024Article
- Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Patterns of Early Neocortical Amyloid-β Accumulation: A PET Population-Based Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- Plasma Leptin and Alzheimer Protein Pathologies Among Older Adults.JAMA network open · 2024Article
- Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.Alzheimer's research & therapy · 2024Article
- Article
- Body mass index and two-year change of in vivo Alzheimer's disease pathologies in cognitively normal older adults.Alzheimer's research & therapy · 2023Article
- Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023Article
Corrections and comments
- Commented on by
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
Amyloid-β (Aβ) deposition as seen on PET using an Aβ-binding agent is a critical diagnostic biomarker for Alzheimer disease (AD). Some reports suggest using white matter (WM) as a reference region for quantification of serial Aβ PET studies; however, nonspecific WM retention in Aβ PET in people with dementia or cognitively unimpaired (CU) has been widely reported and is poorly understood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.